Publications
- Novel Treatment Options in Metastatic Esophageal Carcinoma: Checkpoint Inhibitors in Combination Therapies2023 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- A novel anti-CD47-targeted blockade promotes immune activation in human soft tissue sarcoma but does not potentiate anti-PD-1 blockade2023 | Second Faculty of Medicine, First Faculty of Medicine
- The expression profiles of CD47 in the tumor microenvironment of salivary gland cancers: a next step in histology-driven immunotherapy2022 | Second Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University
- Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety2022 | Second Faculty of Medicine, First Faculty of Medicine
- The Immune Contexture of Liposarcoma and Its Clinical Implications2022 | Second Faculty of Medicine, First Faculty of Medicine
- Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab2022 | Second Faculty of Medicine
- The Periphery of Salivary Gland Carcinoma Tumors Reveals a PD-L1/PD-1 Biomarker Niche for the Evaluation of Disease Severity and Tumor-Immune System Interplay2021 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- Interleukin-1 Blockade in Polygenic Autoinflammatory Disorders: Where Are We now?2021 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives2021 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- Fas-Fas Ligand Interplay in the Periphery of Salivary Gland Carcinomas as a New Checkpoint Predictor for Disease Severity and Immunotherapy Response2021 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
Loading network view...